Carteolol Hydrochloride CAS 51781-21-6

Product Description:

Product Name: Carteolol hydrochloride CAS NO: 51781-21-6

Synonyms:

5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one,hydrochloride;

Carteolol monohydrochloride;

Carteolol Hydrochloride;

Chemical & Physical Properties:

Appearance: Crystalline Solid

Assay :≥99.0%

Density: 1.13g/cm3

Boiling Point: 518.6℃ at 760mmHg

Melting Point: 278℃

Flash Point: 267.4℃

Storage Condition: Refrigerator

Safety Information:

RTECS: VC8282000

HS Code: 2933790002

β-Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma. Carteolol HCl is a non-selective beta blocker used to treat glaucoma.Target: Beta adrenergic ReceptorCarteolol HCl is a beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. Carteolol hydrochloride at 1 mmol/L (P<0.05) significantly inhibited H2O2-induced cell damage and was able to scavenge O2 (EC50 value: 48 mmol/L). carteolol hydrochloride has a protective action against UVB-induced HCEC damage, and its radical scavenging ability may be an important basis for this effect. The new alginate formulation of long-acting carteolol 1% given once daily is as effective as standard 1% carteolol given twice daily, with no meaningful differences regarding safety. This efficacy wasy was verified at 9 AM (24 hours after the last drop of long-acting carteolol or 12 hours after that of standard carteolol) and at 11 AM (2 hours after the morning drop). The new alginate formulation of long-acting carteolol 1% given once a day is effective and well tolerated by glaucoma patients who require chronic treatment.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.